No Detail Found!

Effects of tgf-β3/pdgf-bb-heparin-hyaluronic acid hydrogel on rabbit knee osteoarthritis

Author(s)
Z.Y. Wang Department of Orthopaedic and Reconstructive Surgery, South China Hospital Affiliated to Shenzhen University, Shenzhen 158000, Guangdong, China
L. Shi Department of Orthopaedic Surgery, Rehabilitation Hospital Affiliated to National Rehabilitation AIDS Research Center, Beijing 100000, China
W.T. Chen Material Supply Center, Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang, China
B. Feng Department of Orthopaedic Medicine, Third Affiliated Hospital of Inner Mongolia Medical University, Baotou 014000, Inner Mongolia, China.
Abstract
Current treatments for knee osteoarthritis (KOA) can alleviate symptoms but fail to repair damaged articular cartilage, while long-term use may lead to side effects. This study aimed to investigate the role of transforming growth factor (TGF)-ß3-platelet-derived growth factor (PDGF)-B chain homodimer (BB)/heparin-hyaluronic acid (HA) hydrogel in rabbit KOA to achieve effective articular cartilage repair. Methacrylated hyaluronic acid (HAMA) and heparin (HepMA) were synthesized and utilized as matrices to prepare HepMA-HAMA hydrogel microspheres (MSs). Subsequently, the MSs were co-incubated with TGF-ß3 and PDGF-BB to fabricate heparin-HA hydrogel MSs loaded with dual growth factors (HepMA-HAMA@DGFs). The drug loading, release , degradation and biocompatibility characteristics of the prepared hydrogel MSs were examined. New Zealand rabbits were utilized as experimental animals, and a KOA rabbit model was established. Physiological saline (Model group), HA (HA group), hydrogel MSs (HepMA-HAMA group and HepMA-HAMA@DGFs group) were injected into the joint cavity. Healthy rabbits served as the control. Behavioral analysis, knee joint histology, and expression differences of matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinases-1 (TIMP-1), and vascular endothelial growth factor (VEGF) in knee articular cartilage were calculated. Results: The MSs exhibited sustained cumulative drug release and in vitro degradation. Co-culturing HepMAHAMA@ DGFs MSs with mouse bone marrow mesenchymal stem cells (MSCs) showed minimal changes in cell growth. In rabbits, the model group exhibited increased Lequesne MG scores, upregulated expression of MMP-13 and VEGF in knee articular cartilage, and downregulated expression of TIMP-1 versus Control (P<0.05). HepMA-HAMA and HepMA-HAMA@DGFs groups showed reduced requesne MG scores, downregulated expression of MMP-13 and VEGF in knee articular cartilage, and upregulated expression of TIMP-1 versus Model group (P<0.05). Compared with the HepMA-HAMA group, HepMA-HAMA@DGFs group exhibited decreased Lequesne MG scores, downregulated expressions of MMP-13 and VEGF in knee articular cartilage of rabbits, and upregulated expression of TIMP-1 (P<0.05). Conclusion: These findings indicate that HepMA-HAMA@DGFs hydrogel MSs have favorable drug release properties, degradation performance, and biocompatibility. Furthermore, HepMA-HAMA@DGFs hydrogel MSs can reduce the expression of MMP-13 and VEGF in KOA cartilage of rabbits, increase the expression of TIMP-1, and promote cartilage repair, thereby exerting therapeutic effects in the treatment of KOA in rabbits.
Publication Details
Page(s) 116-127
Published Journal: Journal of Animal and Plant sciences, Volume: 36, Issue: 1, Year: 2026

Request the full text from PASTIC

Keywords
Growth factor, drug release rate, TGF-ß3-PDGF-BB/heparin-hyaluronic acid hydrogel, cartilage repair, Knee Osteoarthritis
References
. .. 1 0 . 2ha/dm 8 96, : .
0

Citations

0

Downloads

23

Views